4,6-Dimethyl-2-(2-morpholino-2-oxoethoxy)nicotinonitrile

Catalog No. :
ACSZVB195
CAS No. :
916038-47-6
Molecular Formula :
C14H17N3O3
Molecular Weight :
275.31

IUPAC Name:4,6-dimethyl-2-(2-morpholino-2-oxoethoxy)nicotinonitrile

4,6-Dimethyl-2-(2-morpholino-2-oxoethoxy)nicotinonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25mg98%$103.00Login to see priceIn stockInquiry
50mg98%$174.00Login to see priceIn stockInquiry
100mg98%$297.00Login to see priceInquiryInquiry
250mg98%$564.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4,6-Dimethyl-2-(2-morpholino-2-oxoethoxy)nicotinonitrile
IUPAC Name4,6-dimethyl-2-(2-morpholino-2-oxoethoxy)nicotinonitrile
Molecular FormulaC14H17N3O3
Molecular Weight275.31
SMILESN#CC1=C(C)C=C(C)N=C1OCC(N2CCOCC2)=O
InChI KeyXARGLDJCVPQGEH-UHFFFAOYSA-N
Synonym4,6-Dimethyl-2-[2-(4-morpholinyl)-2-oxoethoxy]-3-pyridinecarbonitrile;Pim-1 kinase inhibitor 8;4,6-Dimethyl-2-(2-morpholino-2-oxoethoxy)nicotinonitrile
CAS No.916038-47-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACSZVB195 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSZVB195 route product structure diagram
    ACSZVB195916038-47-6 In Stock
Inquiry

2. ACSZVB195 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACSZVB195 route product structure diagram
    ACSZVB195916038-47-6 In Stock
Inquiry

Comments (0)